ARCHIVES

Phase II Study Of Pfizer Drug Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI To Move From Westwood, Landow, Blair Bldgs; Kinsella Names UW Oncology Chairman

October 9, 1987

House Subcommittee voted $1.011 Billion For NCU 1981 Fiscal Year Budget In Closed Door Meeting

August 8, 1980

Core Grant Guideline Revisions, Comprehensive Center Characteristics Changes Still Coming Up

July 13, 1979

ASCO Sees Efforts Pay Off In Health Care Reform: Clinical Trials

October 1, 1993

Diptheria Toxin Prompts Immune System To Kill Cancer

December 29, 2006

Oxford Univ. Receives Funds To Create Drug Design Center.

October 6, 2000